ReviewFrontiers in oncology2021

The Application of CRISPR/Cas9 Technology for Cancer Immunotherapy: Current Status and Problems.

Luyao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.